Thiamine Hydrochloride Injection, Solution
Product Images NDC 43598-050

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Thiamine Hydrochloride (NDC 43598-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (6f1105a8 624b 4a74 A14f 8738ef4d7193 01)

FDA Label Image

Carton (Carton)

Carton (Carton)
This appears to be a product description for a Thiamine HCI Injection, USP contained in multiple dose vials. The dosage, storage conditions, and composition of the injection are provided along with a warning that the product contains no more than 400 mcg/L of aluminum. There are also details about the packaging and an included package insert.*
FDA Label Image
FDA Label Image

Vial (Vial)

Vial (Vial)
This is a description of a pharmaceutical product. It is a 2 mL multiple dose vial of Injection USP developed by Dr. Reddy's Laboratories, Inc. The product contains 200 mg per 2 mL of solution, with a concentration of 100 mg per mL. It is intended for intramuscular or intravenous use and must be protected from light. The distributor of the product is Thlamme HCI, and it was manufactured in India. The expiry date of the product is 107/2022, and it bears the code: DRUGS/AP/3/2014.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.